SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-126891
Filing Date
2021-04-22
Accepted
2021-04-22 17:08:16
Documents
14
Period of Report
2021-04-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d129302d8k.htm   iXBRL 8-K 34334
2 EX-99.1 d129302dex991.htm EX-99.1 14172
6 GRAPHIC g129302g50a03.jpg GRAPHIC 4620
  Complete submission text file 0001193125-21-126891.txt   190702

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA jazz-20210422.xsd EX-101.SCH 3076
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE jazz-20210422_lab.xml EX-101.LAB 18840
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jazz-20210422_pre.xml EX-101.PRE 11843
7 EXTRACTED XBRL INSTANCE DOCUMENT d129302d8k_htm.xml XML 3535
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 21845569
SIC: 2834 Pharmaceutical Preparations